🔎 Trials Near Me

Pradžia › Melanoma › Texas › Dallas

Melanoma klinikiniai tyrimai Dallas, TX

20 tyrimai dėl Melanoma ieško dalyvių vietose Dallas ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

DESTINY-PANTUMOUR04

Renkami dalyviaiStebimasis tyrimas
  • Research Site, Dallas
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07124000

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Renkami dalyviai3 fazė
  • Texas Oncology - Medical City, Dallas
  • Texas Oncology, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06246916

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Renkami dalyviai1/2 fazė
  • Baylor, Scott and White Research Institute, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT06047379

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Renkami dalyviaiStebimasis tyrimas
  • UT Southwestern Medical Center, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT05059444

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Renkami dalyviai1/2 fazė
  • UT Southwestern, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07288112

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Renkami dalyviai1/2 fazė
  • Texas Oncology - Dallas SCRI, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT07287917

Project: Every Child for Younger Patients With Cancer

Renkami dalyviaiStebimasis tyrimas
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Iki 25 metų · Visoms lytims · Atnaujinta 2026-08-25 · NCT02402244

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Renkami dalyviai1/2 fazė
  • Texas Oncology, P.A., Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT06330064

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Renkami dalyviai1/2 fazė
  • Call for Information (Investigational Site 0054), Dallas
6 Months – 17 Years · Visoms lytims · Atnaujinta 2026-07-06 · NCT02332668

Identification of Metabolic Phenotypes Associated With Melanoma Metastasis

Renkami dalyviaiStebimasis tyrimas
  • University of Texas Southwestern Medical Center, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-02 · NCT06400550

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Renkami dalyviai1/2 fazė
  • Mary Crowley Cancer Research, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-15 · NCT05379985

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Renkami dalyviai3 fazė
  • Texas Retina Associates - Dallas, Dallas
  • University of Texas Southwestern Medical Center-5323 Harry Hines Blvd, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-06 · NCT07015190

A Study of VET3-TGI in Patients With Solid Tumors

Renkami dalyviai1 fazė
  • Mary Crowley Cancer Research, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-07 · NCT06444815

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Renkami dalyviai2/3 fazė
  • UT Southwestern Medical Center, Dallas
Visi amžiai · Visoms lytims · Atnaujinta 2026-04-02 · NCT06581406

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

Renkami dalyviai1/2 fazė
  • Research Site, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-02 · NCT06956690

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Renkami dalyviai1 fazė
  • NEXT Dallas, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-21 · NCT07317505

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Renkami dalyviai1/2 fazė
  • Research Site 120, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-11-21 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Renkami dalyviaiStebimasis tyrimas
  • Massive Bio SYNERGY-AI site, Dallas
Visi amžiai · Visoms lytims · Atnaujinta 2025-10-28 · NCT03452774

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Renkami dalyviai1/2 fazė
  • Mary Crowley Cancer Research, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-10-08 · NCT04370587

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Renkami dalyviai1 fazė
  • NEXT Oncology, Dallas, Dallas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2024-01-26 · NCT05746897

Melanoma tyrimai kituose miestuose

Kiti tyrimai Dallas

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.